We are live on ! Find out more
PAHC icon

Phibro Animal Health

155 hedge funds and large institutions have $522M invested in Phibro Animal Health in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 61 increasing their positions, 41 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

49% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 41

8% more funds holding

Funds holding: 143155 (+12)

0.81% more ownership

Funds ownership: 99.65%100.45% (+0.81%)

4% less capital invested

Capital invested by funds: $541M → $522M (-$19.2M)

Holders
155
Holders Change
+12
Holders Change %
+8.39%
% of All Funds
3.86%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
27
Increased
61
Reduced
41
Closed
10
Calls
Puts
Net Calls
Net Calls Change

PAHC Hedge Fund Activity: Q1 2017 in Review

155 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2017, worth a combined $522M — down 3.5% from $541M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PAHC positions and 10 closed out — a net gain of 17 holders — while 61 added to existing stakes and 41 trimmed.

The largest buyer was BlackRock, adding an estimated $81.3M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $6.25M.

  • 155 institutional investors held Phibro Animal Health (PAHC) as of Q1 2017, up from 143 in Q4 2016.
  • Funds reported $522M of Phibro Animal Health stock for Q1 2017, down 3.5% quarter-over-quarter.
  • 27 funds opened new Phibro Animal Health positions in Q1 2017 and 10 closed out, a net change of +17 holders.
  • The largest Phibro Animal Health buyer in Q1 2017 was BlackRock, an estimated $81.3M added.
  • The largest Phibro Animal Health seller in Q1 2017 was Hotchkis & Wiley Capital Management, an estimated $6.25M sold.

Based on aggregated 13F filings for Q1 2017.